Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

289 records found for:
Title = Substance Use Disorders
Year =

  1. Scheibein F, Caballeria E, Taher MA, Arya S, Bancroft A, Dannatt L, De Kock C, Chaudhary NI, Gayo RP, Ghosh A, Gelberg L, Goos C, Gordon R, Gual A, Hill P, Jeziorska I, Kurcevic E, Lakhov A, Maharjan I, Matrai S, Morgan N, Paraskevopoulos I, Puharic Z, Sibeko G, Stola J, Tiburcio M, Tay Wee Teck J, Tsereteli Z, López-Pelayo H. Optimizing Digital Tools for the Field of Substance Use and Substance Use Disorders: Backcasting Exercise. JMIR human factors. 2023 Dec 12; 10:e46678.
  2. Shuey B, Suda KJ, Halbisen A, Wen H, Wharam JF, Rosland AM, Liebschutz JM. Anti-hypertensive Medication Use Among People with and without Substance Use Disorders. Journal of general internal medicine. 2023 Nov 27.
  3. Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of substance use and addiction treatment. 2023 Sep 24; 209175.
  4. Han BH, Bronson J, Washington L, Yu M, Kelton K, Tsai J, Finlay AK. Co-occurring Medical Multimorbidity, Mental Illness, and Substance Use Disorders Among Older Criminal Legal System-Involved Veterans. Medical care. 2023 Jul 1; 61(7):477-483.
  5. Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of addiction medicine. 2023 May 1; 17(3):278-285.
  6. Gao YA, Krans EE, Chen Q, Rothenberger SD, Zivin K, Jarlenski MP. Sex-related differences in the prevalence of substance use disorders, treatment, and overdose among parents with young children. Addictive behaviors reports. 2023 Jun 1; 17:100492.
  7. Fast N, van Kessel R, Humphreys K, Ward NF, Roman-Urrestarazu A. The Evolution of Telepsychiatry for Substance Use Disorders During COVID-19: a Narrative Review. Current addiction reports. 2023 Apr 25; 10(2):187-197.
  8. Lin C, Pham H, Zhu Y, Clingan SE, Lin LA, Murphy SM, Campbell CI, Sorrell TR, Liu Y, Mooney LJ, Hser YI. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and Alcohol Dependence. 2023 Jan 1; 242:109711.
  9. Mackey KM, Anderson JK, Williams BE, Ward RM, Parr NJ. Evidence Brief: Psychedelic Medications for Mental Health and Substance Use Disorders. Evidence Synthesis Program, Health Services Research and Development Service. Washington, DC: Office of Research and Development, Department of Veterans Affairs; 2022 Oct 1. 45 p. Report No.: VA ESP Project #09-199.
  10. Kehle-Forbes SM, Nelson D, Norman SB, Schnurr PP, Shea MT, Ackland PE, Meis L, Possemato K, Polusny MA, Oslin D, Hamblen JL, Galovski T, Kenny M, Babajide N, Hagedorn H. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial. Contemporary clinical trials. 2022 Sep 1; 120:106876.
  11. Perry C, Liberto J, Milliken C, Burden J, Hagedorn H, Atkinson T, McKay JR, Mooney L, Sall J, Sasson C, Saxon A, Spevak C, Gordon AJ, VA/DoD Guideline Development Group. The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of internal medicine. 2022 May 1; 175(5):720-731.
  12. Hasin DS, Fink DS, Olfson M, Saxon AJ, Malte C, Keyes KM, Gradus JL, Cerdá M, Maynard CC, Keyhani S, Martins SS, Livne O, Mannes ZL, Sherman SE, Wall MM. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records. Drug and Alcohol Dependence. 2022 May 1; 234:109383.
  13. Schmidt EM, Liu P, Combs A, Trafton J, Asch S, Harris AHS. Surveying the Landscape of Quality-of-Care Measures for Mental and Substance Use Disorders. Psychiatric services (Washington, D.C.). 2022 Aug 1; 73(8):880-888.
  14. Blakey SM, Campbell SB, Simpson TL. Associations Between Lifetime Panic Attacks, Posttraumatic Stress Disorder, and Substance Use Disorders in a Nationally Representative Sample. Journal of Dual Diagnosis. 2022 Jan 1; 18(1):21-32.
  15. Hatoum AS, Johnson EC, Colbert SMC, Polimanti R, Zhou H, Walters RK, Gelernter J, Edenberg HJ, Bogdan R, Agrawal A. The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022 Sep 1; 47(10):1739-1745.
  16. Jones AL, Gelberg L, deRussy AJ, Varley AL, Riggs KR, Gordon AJ, Kertesz SG. Low Uptake of Secure Messaging Among Veterans With Experiences of Homelessness and Substance Use Disorders. Journal of addiction medicine. 2021 Nov 1; 15(6):508-511.
  17. Scott JC, Lynch KG, Cenkner DP, Kehle-Forbes SM, Polusny MA, Gur RC, Chen S, Foa EB, Oslin DW. Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders. Journal of consulting and clinical psychology. 2021 Nov 1; 89(11):937-946.
  18. Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction (Abingdon, England). 2022 Apr 1; 117(4):946-968.
  19. Gelernter J, Polimanti R. Genetics of substance use disorders in the era of big data. Nature reviews. Genetics. 2021 Nov 1; 22(11):712-729.
  20. Haffajee RL, Faherty LJ, Zivin K. Pregnant Women with Substance Use Disorders - The Harm Associated with Punitive Approaches. The New England journal of medicine. 2021 Jun 24; 384(25):2364-2367.
  21. Schmidt EM, Wright D, Cherkasova E, Harris AHS, Trafton J. Evaluating and Improving Engagement in Care After High-Intensity Stays for Mental or Substance Use Disorders. Psychiatric services (Washington, D.C.). 2022 Jan 1; 73(1):18-25.
  22. Santa Ana EJ, LaRowe SD, Gebregziabher M, Morgan-Lopez AA, Lamb K, Beavis KA, Bishu K, Martino S. Randomized controlled trial of group motivational interviewing for veterans with substance use disorders. Drug and Alcohol Dependence. 2021 Jun 1; 223:108716.
  23. Clair K, Ijadi-Maghsoodi R, Nazinyan M, Gabrielian S, Kalofonos I. Veteran Perspectives on Adaptations to a VA Residential Rehabilitation Program for Substance Use Disorders During the Novel Coronavirus Pandemic. Community mental health journal. 2021 Jul 1; 57(5):801-807.
  24. Dargis M, Patrick CJ, Blonigen DM. Relevance of psychopathic traits to therapeutic processes and outcomes for veterans with substance use disorders. Personality disorders. 2022 Jan 1; 13(1):64-74.
  25. Johnson-Kwochka A, Aalsma MC, Monahan PO, Salyers MP. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders. Drug and Alcohol Dependence. 2021 Apr 1; 221:108600.
  26. Dandachi D, de Groot A, Rajabiun S, Rajashekara S, Davila JA, Quinn E, Cabral HJ, Wilson IB, Giordano TP. Reliability and Validity of a Brief Self-Report Adherence Measure among People with HIV Experiencing Homelessness and Mental Health or Substance Use Disorders. AIDS and behavior. 2021 Feb 1; 25(2):322-329.
  27. Doshi R, Dave M, Majmundar M, Kumar A, Adalja D, Shariff M, Desai R, Ziaeian B, Vallabhajosyula S. National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations. Heart & lung : the journal of critical care. 2021 Mar 1; 50(2):244-251.
  28. Ilgen MA, Coughlin LN, Bohnert ASB, Chermack S, Price A, Kim HM, Jannausch M, Blow FC. Efficacy of a Psychosocial Pain Management Intervention for Men and Women With Substance Use Disorders and Chronic Pain: A Randomized Clinical Trial. JAMA psychiatry. 2020 Dec 1; 77(12):1225-1234.
  29. Jones AL, Cochran SD, Rafferty J, Taylor RJ, Mays VM. Lifetime and Twelve-Month Prevalence, Persistence, and Unmet Treatment Needs of Mood, Anxiety, and Substance Use Disorders in African American and U.S. versus Foreign-Born Caribbean Women. International journal of environmental research and public health. 2020 Sep 25; 17(19).
  30. Jarlenski M, Krans EE, Chen Q, Rothenberger SD, Cartus A, Zivin K, Bodnar LM. Substance use disorders and risk of severe maternal morbidity in the United States. Drug and Alcohol Dependence. 2020 Nov 1; 216:108236.
  31. Simpson TL, Hawrilenko M, Goldberg S, Browne K, Lehavot K, Borowitz M. Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders. Journal of consulting and clinical psychology. 2020 Nov 1; 88(11):1039-1051.
  32. Adams RS, Garnick DW, Harris AHS, Merrick EL, Hofmann K, Funk W, Williams TV, Larson MJ. Assessing the postdeployment quality of treatment for substance use disorders among Army enlisted soldiers in the Military Health System. Journal of substance abuse treatment. 2020 Jul 1; 114:108026.
  33. McBain SA, Woodward E, Palmer BE, Landes SJ, Wilson MP. Patients accept screening for mental health and substance use disorders while ED clinicians support only if able to refer. The American journal of emergency medicine. 2020 Dec 1; 38(12):2727-2729.
  34. Marsch LA, Campbell A, Campbell C, Chen CH, Ertin E, Ghitza U, Lambert-Harris C, Hassanpour S, Holtyn AF, Hser YI, Jacobs P, Klausner JD, Lemley S, Kotz D, Meier A, McLeman B, McNeely J, Mishra V, Mooney L, Nunes E, Stafylis C, Stanger C, Saunders E, Subramaniam G, Young S. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Journal of substance abuse treatment. 2020 Mar 1; 112S:4-11.
  35. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction (Abingdon, England). 2020 Jun 1; 115(6):1098-1112.
  36. Pollack HA, Humphreys KN. Reducing violent incidents between police officers and people with psychiatric and/or substance use disorders. The Annals of the American Academy of Political and Social Science. 2020 Jan 1; 687(1):166-184.
  37. Kim B, Bolton RE, Hyde J, Fincke BG, Drainoni ML, Petrakis BA, Simmons MM, McInnes DK. Coordinating across correctional, community, and VA systems: applying the Collaborative Chronic Care Model to post-incarceration healthcare and reentry support for veterans with mental health and substance use disorders. Health & justice. 2019 Dec 12; 7(1):18.
  38. Kehle-Forbes SM, Chen S, Polusny MA, Lynch KG, Koffel E, Ingram E, Foa EB, Van Horn DHA, Drapkin ML, Yusko DA, Oslin DW. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug and Alcohol Dependence. 2019 Dec 1; 205:107647.
  39. Schmidt EM, Barnes J, Chen C, Trafton J, Frayne S, Harris AHS. Patient and Health Care Factors Associated With Long-term Diabetes Complications Among Adults With and Without Mental Health and Substance Use Disorders. JAMA Network Open. 2019 Sep 4; 2(9):e1912060.
  40. Kathuria H, Seibert RG, Cobb V, Weinstein ZM, Gowarty M, Helm ED, Wiener RS. Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods Study. Journal of addiction medicine. 2019 Sep 1; 13(5):338-345.
  41. Goldberg SB, Livingston WS, Blais RK, Brignone E, Suo Y, Lehavot K, Simpson TL, Fargo J, Gundlapalli AV. A positive screen for military sexual trauma is associated with greater risk for substance use disorders in women veterans. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2019 Aug 1; 33(5):477-483.
  42. Ronzitti S, Loree AM, Potenza MN, Decker SE, Wilson SM, Abel EA, Haskell SG, Brandt CA, Goulet JL. Gender Differences in Suicide and Self-Directed Violence Risk Among Veterans With Post-traumatic Stress and Substance Use Disorders. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2019 Jun 25; 29 Suppl 1:S94-S102.
  43. Ijadi-Maghsoodi R, Quan M, Horton J, Ryan GW, Kataoka S, Lester P, Milburn NG, Gelberg L. Youth Growing Up in Families Experiencing Parental Substance Use Disorders and Homelessness: A High-Risk Population. Journal of child and adolescent psychopharmacology. 2019 Dec 1; 29(10):773-782.
  44. Haverfield MC, Ilgen M, Schmidt E, Shelley A, Timko C. Social Support Networks and Symptom Severity Among Patients with Co-occurring Mental Health and Substance Use Disorders. Community mental health journal. 2019 Jul 1; 55(5):768-776.
  45. Greer N, Ackland P, Sayer N, Spoont M, Taylor B, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review. 2019 Mar 1.
  46. Ecker A, Stanley MA, Smith TL, Teng E, Fletcher TL, Van Kirk N, Amspoker A, Walder A, McIngvale E, Lindsay JA. Co-occurrence of obsessive compulsive disorder and substance use disorders among U.S. military veterans: Prevalence and mental health utilization. Journal of Cognitive Psychotherapy. 2019 Feb 26; 33:23-32.
  47. Kathuria H, Seibert RG, Cobb V, Herbst N, Weinstein ZM, Gowarty M, Jhunjhunwala R, Helm ED, Wiener RS. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study. Addictive Behaviors. 2019 Aug 1; 95:41-48.
  48. McKee MM, Meade MA, Zazove P, Stewart HJ, Jannausch ML, Ilgen MA. The Relationship Between Hearing Loss and Substance Use Disorders Among Adults in the U.S. American journal of preventive medicine. 2019 Apr 1; 56(4):586-590.
  49. Snow SC, Fonarow GC, Ladapo JA, Washington DL, Hoggatt KJ, Ziaeian B. National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients. The American journal of medicine. 2019 Apr 1; 132(4):478-488.e4.
  50. Boden MT, Hoggatt KJ. Substance Use Disorders Among Veterans in a Nationally Representative Sample: Prevalence and Associated Functioning and Treatment Utilization. Journal of studies on alcohol and drugs. 2018 Nov 1; 79(6):853-861.
  51. Owens MD, Chen JA, Simpson TL, Timko C, Williams EC. Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addiction science & clinical practice. 2018 Aug 21; 13(1):19.
  52. Hawkins EJ, Danner AN, Malte CA, Painter JM, Lott AMK, Baer JS. Feasibility of a care management approach for complex substance use disorders and high acute services utilization. Journal of substance abuse treatment. 2018 Sep 1; 92:100-108.
  53. Berg JM, Malte CA, Reger MA, Hawkins EJ. Medical Records Flag for Suicide Risk: Predictors and Subsequent Use of Care Among Veterans With Substance Use Disorders. Psychiatric services (Washington, D.C.). 2018 Sep 1; 69(9):993-1000.
  54. Stimmel MA, Rosenthal J, Blue-Howells J, Clark S, Harris AHS, Rubinsky AD, Bowe T, Finlay AK. The impact of substance use disorders on treatment engagement among justice-involved veterans with posttraumatic stress disorder. Psychological Services. 2019 Nov 1; 16(4):564-571.
  55. Timko C, Ilgen M, Haverfield M, Shelley A, Breland JY. Polysubstance use by psychiatry inpatients with co-occurring mental health and substance use disorders. Drug and Alcohol Dependence. 2017 Nov 1; 180:319-322.
  56. Hepner KA, Paddock SM, Watkins KE, Ounpraseuth ST, Schrader AM, Hudson TJ. Association Between Quality Measures and Perceptions of Care Among Patients With Substance Use Disorders. Psychiatric services (Washington, D.C.). 2017 Nov 1; 68(11):1150-1156.
  57. Watkins KE, Hudson TJ, Hayes C. Association between Quality Measures and Mortality in Individuals with Co-Occurring Mental Health and Substance Use Disorders. Counselor Magazine. 2017 Jul 1;(Jul-Aug):1.
  58. Ilgen MA, Goldman E. Cognitive behavior therapy for suicide in Veterans with substance use disorders. Suicide Prevention [Cyberseminar]. 2017 Jun 12.
  59. Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. Journal of substance abuse treatment. 2017 Aug 1; 79:46-52.
  60. Griffith G, Kumaraswami T, Chrysanthopoulou SA, Mattocks KM, Clark RE. Prescription contraception use and adherence by women with substance use disorders. Addiction (Abingdon, England). 2017 Sep 1; 112(9):1638-1646.
  61. Painter JM, Brignone E, Gilmore AK, Lehavot K, Fargo J, Suo Y, Simpson T, Carter ME, Blais RK, Gundlapalli AV. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders. Psychological Services. 2018 Feb 1; 15(1):11-20.
  62. Hawkins EJ, Lott AMK, Malte CA, Frank AN, Hamilton B, Sayre GG, Painter JM, Baer JS. Patients' perspectives on care management services for complex substance use disorders. Journal of addictive diseases. 2017 Jul 1; 36(3):193-206.
  63. Brignone E, Fargo JD, Blais RK, Carter ME, Samore MH, Gundlapalli AV. Non-routine Discharge From Military Service: Mental Illness, Substance Use Disorders, and Suicidality. American journal of preventive medicine. 2017 May 1; 52(5):557-565.
  64. Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug and Alcohol Dependence. 2017 May 1; 174:128-136.
  65. Paddock SM, Hepner KA, Hudson T, Ounpraseuth S, Schrader AM, Sullivan G, Watkins KE. Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders. Journal of studies on alcohol and drugs. 2017 May 1; 78(4):588-596.
  66. McCullough M, Smelson DA. Methodological Issues and Data Decisions in the Implementation of a Substance Use Disorders Intervention in VA's Homeless Programs. [Cyberseminar]. HSR&D. 2017 Mar 21.
  67. Bohnert KM, Ilgen MA, Louzon S, McCarthy JF, Katz IR. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction (Abingdon, England). 2017 Jul 1; 112(7):1193-1201.
  68. Lagisetty PA, Maust D, Heisler M, Bohnert A. Physical and Mental Health Comorbidities Associated With Primary Care Visits For Substance Use Disorders. Journal of addiction medicine. 2017 Mar 1; 11(2):161-162.
  69. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017 Mar 1; 158(3):526-534.
  70. Nahum-Shani I, Ertefaie A, Lu XL, Lynch KG, McKay JR, Oslin DW, Almirall D. A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders. Addiction (Abingdon, England). 2017 May 1; 112(5):901-909.
  71. Jones AL, Mor MK, Cashy JP, Gordon AJ, Haas GL, Schaefer JH, Hausmann LR. Racial/Ethnic Differences in Primary Care Experiences in Patient-Centered Medical Homes among Veterans with Mental Health and Substance Use Disorders. Journal of general internal medicine. 2016 Dec 1; 31(12):1435-1443.
  72. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. Journal of addiction medicine. 2016 Nov 1; 10(6):418-428.
  73. Santa Ana EJ, LaRowe SD, Armeson K, Lamb KE, Hartwell K. Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation. The American journal on addictions. 2016 Oct 1; 25(7):533-41.
  74. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Sullivan G. Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders. Journal of substance abuse treatment. 2016 Oct 1; 69:1-8.
  75. Gilmore AK, Brignone E, Painter JM, Lehavot K, Fargo J, Suo Y, Simpson T, Carter ME, Blais RK, Gundlapalli AV. Military Sexual Trauma and Co-occurring Posttraumatic Stress Disorder, Depressive Disorders, and Substance Use Disorders among Returning Afghanistan and Iraq Veterans. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2016 Sep 1; 26(5):546-54.
  76. Gabrielian S, Young AS, Greenberg JM, Bromley E. Social support and housing transitions among homeless adults with serious mental illness and substance use disorders. Psychiatric Rehabilitation Journal. 2018 Sep 1; 41(3):208-215.
  77. Lovejoy TI, Demidenko MI. A pilot study of group Acceptance and Commitment Therapy for chronic pain in patients with comorbid substance use disorders. Poster session presented at: American Psychological Association Annual Convention; 2016 Aug 4; Denver, CO.
  78. Chereji E, Kern S, Fuller B, Morasco BJ, Phelps A, Hauser P. Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C. Open medicine journal. 2016 Jul 29; 3(Suppl 1: M5):79-103.
  79. Chermack ST, Bonar EE, Ilgen MA, Walton MA, Cunningham RM, Booth BM, Blow FC. Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders. Journal of interpersonal violence. 2017 Feb 1; 32(4):581-603.
  80. Raynor P, Pope C. The Role of Self-Care for Parents in Recovery From Substance Use Disorders: An Integrative Review of Parental Self-Care. Journal of addictions nursing. 2016 Jul 1; 27(3):180-9.
  81. Jones AL, Mor MK, Cashy JP, Gordon AJ, Haas GL, Schaefer JS, Hausmann LR. Racial/Ethnic Differences in Patient-Centered Medical Home Experiences Among Veterans with Mental Health and Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2016 Jun 27; Boston, MA.
  82. Stimmel M, McGuire J, Rosenthal J, Rubinsky A, Blue-Howells J, Finlay AK. Justice-involved veterans with posttraumatic stress disorder: Understanding the impact of co-occurring substance use disorders on treatment engagement. Paper presented at: International Association of Forensic Mental Health Services Annual Conference; 2016 Jun 21; New York, NY.
  83. Santa Ana EJ, LaRowe K, Lamb K, Hartwell K. Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2016 Jun 11; Palm Springs, CA.
  84. Banducci AN, Bujarski SJ, Bonn-Miller MO, Patel A, Connolly KM. The impact of intolerance of emotional distress and uncertainty on veterans with co-occurring PTSD and substance use disorders. Journal of anxiety disorders. 2016 Jun 1; 41:73-81.
  85. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Poster session presented at: American Pain Society Annual Meeting; 2016 May 2; Austin, TX.
  86. Lembke A, Humphreys K. A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Tobacco Control. 2016 May 1; 25(3):261-2.
  87. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. [Abstract]. Pain. 2016 Apr 1; 17(4):s87.
  88. Vederhus JK, Clausen T, Humphreys K. Assessing understandings of substance use disorders among Norwegian treatment professionals, patients and the general public. BMC health services research. 2016 Feb 13; 16:52.
  89. Glynn LH, Kendra MS, Timko C, Finlay AK, Blodgett JC, Maisel NC, Midboe AM, McGuire JF, Blonigen DM. Facilitating treatment access and engagement for justice-involved Veterans with substance use disorders. Criminal justice policy review. 2016 Feb 4; 27(2):doi: 10.1177/0887403414560884.
  90. Lan CW, Fiellin DA, Barry DT, Bryant KJ, Gordon AJ, Edelman EJ, Gaither JR, Maisto SA, Marshall BD. The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods. The American journal on addictions. 2016 Jan 1; 25(1):7-24.
  91. Outcalt J, Dimaggio G, Popolo R, Buck K, Chaudoin-Patzoldt KA, Kukla M, Olesek KL, Lysaker PH. Metacognition moderates the relationship of disturbances in attachment with severity of borderline personality disorder among persons in treatment of substance use disorders. Comprehensive psychiatry. 2016 Jan 1; 64:22-8.
  92. Heslin KC, Gable A, Dobalian A. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers? Women's health issues : official publication of the Jacobs Institute of Women's Health. 2015 Nov 1; 25(6):666-72.
  93. Hawkins EJ. Feasibility And Acceptability Of A Collaborative Care Management Approach For Patients With Complex And Chronic Substance Use Disorders. Poster session presented at: Society for Research in Psychopathology Meeting; 2015 Oct 18; New Orleans, LA.
  94. Blonigen DM, Finney JW, Wilbourne P, Moos RH. Psychosocial treatments for substance use disorders. In: Nathan PE, Gorman JM, editors. A guide to treatments that work. 4 ed. New York, NY: Oxford University Press; 2015. 731-761 p.
  95. Gabrielian SE, Bromley E, Greenburg J, Young AS. The Social Context of Housing Transitions among Homeless Veterans with Serious Mental Illness and Substance Use Disorders. Paper presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  96. Cucciare MA, Cheung RC, Rongey C. Treating substance use disorders in patients with hepatitis C. [Editorial]. Addiction. 2015 Jul 1; 110(7):1057-9.
  97. Harris AH, Ellerbe L, Phelps TE, Finney JW, Bowe T, Gupta S, Asch SM, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Journal of substance abuse treatment. 2015 Jun 1; 53:16-21.
  98. Ilgen MA. Intervening to reduce suicide risk in Veterans with substance use disorders. Paper presented at: Military Operational Medicine Research Program In Progress Review Meeting; 2015 May 13; Fort Detrick, MD.
  99. Wasmuth S. Occupation-based intervention for substance use disorders: A systematic review. Poster session presented at: American Occupational Therapy Association Annual Conference; 2015 Apr 16; Nashville, TN.
  100. Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S. Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration. Medical care. 2015 Apr 1; 53(4 Suppl 1):S105-11.
  101. Gabrielian S, Bromley E, Hellemann GS, Kern RS, Goldenson NI, Danley ME, Young AS. Factors affecting exits from homelessness among persons with serious mental illness and substance use disorders. The Journal of clinical psychiatry. 2015 Apr 1; 76(4):e469-76.
  102. Humphreys KN. Circles of Recovery: Mutual Help Organizations for Substance Use Disorders. Presented at: University of Chicago School for Social Service Administration Center for Health Administration Studies Michael M. Davis Seminar Series; 2015 Mar 31; Chicago, IL.
  103. Santa Ana EJ, LaRowe S, Lamb K, Tompkins M, Hartwell K. Impact of Group Motivational Interviewing on Enhancing Treatment Engagement for Homeless Veterans with Nicotine Dependence and other Substance Use Disorders: A Pilot Investigation. Paper presented at: American Academy of Addiction Psychiatry Annual Meeting; 2014 Dec 4; Aventura, FL.
  104. Humphreys K, Frank RG. The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction (Abingdon, England). 2014 Dec 1; 109(12):1957-8.
  105. Finlay AK, McGuire J, Rosenthal J, Blue-Howells J, Binswanger I, Smelson D, Sawh L, Timko C, Blodgett JC, Bowe T, Harris A, Clark SC, Asch S, Frayne S. Gender differences in mental health and substance use disorders among justice-involved Veterans after prison incarceration. Poster session presented at: American Society of Criminology Annual Meeting; 2014 Nov 20; San Francisco, CA.
  106. Stimmel MA, Harris AHS, Bowe T, Finlay AK. Co-occurring post-traumatic stress disorder and substance use disorders among Veterans exiting prison. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  107. McLellan AT, Starrels JL, Tai B, Gordon AJ, Brown R, Ghitza U, Gourevitch M, Stein J, Oros M, Horton T, Lindblad R, McNeely J. Can substance use disorders be managed using the chronic care model? Review and recommendation from a NIDA Consensus Group. Public Health Reviews. 2014 Sep 1; 35(2):1-14.
  108. Pilkey D, Steinberg H, Martino S. Evidence-based Treatments for Substance Use Disorders. In: Kaye AD, Vadivelu N, Urman RD, editors. Substance Abuse: Inpatient and Outpatient Management for Every Clinician. New York, NY: Springer; 2014. Chapter 17. 209-28 p.
  109. Maisto S, Jenkins J, Gordon AJ. SUD QUERI funding opportunity (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2014 Aug 19; 3(6).
  110. Gordon AJ, Maisto S, Jenkins J. Department of Veterans Affairs Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin (Featured SUD QUERI Research Project: Effectiveness of Brief Alcohol Counseling Implementation). [Newsletter]. 2014 Aug 4; 3(5).
  111. Blonigen DM, Bui L, Harris AH, Hepner KA, Kivlahan DR. Perceptions of behavioral health care among veterans with substance use disorders: results from a national evaluation of mental health services in the Veterans Health Administration. Journal of substance abuse treatment. 2014 Aug 1; 47(2):122-9.
  112. Timko C, Cucciare MA, Ilgen M. Facilitating care transitions among patients with substance use disorders. VA HSR&D FORUM: Translating research into quality health care for Veterans. 2014 Aug 1; 6.
  113. Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addiction science & clinical practice. 2014 Jul 9; 9(1):12.
  114. Callegari LS, Zhao X, Nelson KM, Lehavot K, Bradley KA, Borrero S. Associations of mental illness and substance use disorders with prescription contraception use among women veterans. Contraception. 2014 Jul 1; 90(1):97-103.
  115. Gordon AJ, Maisto S, Jenkins J. Brief alcohol intervention training for integrated providers in primary care (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2014 Jun 30; 3(4).
  116. Gros DF, Back SE, Killeen T, Teer A, Beylotte F, McCauley JL, Hellmuth J, Brady KT. Gender differences in trauma and substance use characteristics among Veterans with PTSD and substance use disorders. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  117. Cheney AM, Dunn A, Booth BM, Frith L, Curran GM. Incorporating women Veterans' preferences into treatments for co-occurring mental health and substance use disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 8; San Diego, CA.
  118. Finlay AK, McGuire J, Rosenthal J, Blue-Howells J, Binswanger I, Blodgett JC, Bowe T, Harris AH, Asch SM, Frayne SM. Women justice-involved Veterans: Mental health and substance use disorders. Poster session presented at: AcademyHealth Gender and Health Interest Group Annual Meeting; 2014 Jun 7; San Diego, CA.
  119. Sellinger JJ. All roads lead to Rome: Furthering physician involvement in the care of patients with substance use disorders. [Newsletter]. 2014 May 14; 4(2).
  120. Bonn-Miller MO. Cannabis Use: Treatment and Policy Implications. VAPAHCS Substance Use Disorders Clinical Licensure Training Series, Palo Alto, CA. 2014 Apr 30.
  121. Gabrielian S, Bromley E, Hellemann G, Goldenson N, Danley M, Young AS. Improving housing outcomes for homeless persons with serious mental illness and co-occurring substance use disorders. Poster session presented at: National Institute of Mental Health Mental Health Services Research Annual Conference; 2014 Apr 4; Bethesda, MD.
  122. Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO. Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders. International review of psychiatry (Abingdon, England). 2014 Apr 1; 26(2):237-47.
  123. Gordon AJ, Maisto S, Jenkins J. Department of Veterans Affairs Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin. [Newsletter]. 2014 Mar 28; 3(2).
  124. Sullivan M, Vanderlip E, Edlund MJ, Hudson TJ. Characteristics and treatment interests among individuals with substance use disorders and a history of past six-month violence: Findings from an emergency department study. Paper presented at: American Academy of Pain Medicine Annual Meeting; 2014 Mar 6; Phoenix, AZ.
  125. Bonn-Miller MO. Cannabis: Characteristics, Prevalence, Correlates, Medical Use, and Treatment. Invited talk to 2nd year Substance Use Disorders Class (Dr. Nancy Haug, Professor), Palo Alto University, Palo Alto, CA. 2014 Feb 28.
  126. Blodgett JC, Maisel NC, Fuh IL, Wilbourne PL, Finney JW. How effective is continuing care for substance use disorders? A meta-analytic review. Journal of substance abuse treatment. 2014 Feb 1; 46(2):87-97.
  127. Williams EC, Rubinsky AD, Lapham GT, Chavez LJ, Rittmueller SE, Hawkins EJ, Grossbard JR, Kivlahan DR, Bradley KA. Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening. Drug and Alcohol Dependence. 2014 Feb 1; 135:95-103.
  128. Chermack ST, Murray R, Kraus S, Walton MA, Cunningham RM, Barry KL, Booth BM, Blow FC. Characteristics and treatment interests among individuals with substance use disorders and a history of past six-month violence: findings from an emergency department study. Addictive Behaviors. 2014 Jan 1; 39(1):265-72.
  129. Babson KA, Del Re AC, Bonn-Miller MO, Woodward SH. The comorbidity of sleep apnea and mood, anxiety, and substance use disorders among obese military veterans within the Veterans Health Administration. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2013 Dec 15; 9(12):1253-8.
  130. Jain S, Hernandez J, Rosen CS, Lindley S. The peer support program: An innovative clinical program for Veterans with PTSD and substance use disorders living in rural California. Presented at: International Society for Traumatic Stress Studies Annual Symposium; 2013 Nov 7; Philadelphia, PA.
  131. Harris AH, Finney J, Asch S, Ellerbe L, Phelps T, Bowe T, Gupta S, Humphreys K, Trafton J. Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  132. Hepner KA, Paddock SM, Watkins KE, Blonigen DM, Pincus H. Perceptions of care among Veterans with substance use disorders. Presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  133. Gordon AJ, Harding JD. Length of treatment evidence (DVA Substance Use Disorders QUERI Primary Care Work Group Monthly e-Bulletin). [Newsletter]. 2013 Oct 6; 8(3).
  134. Flückiger C, Del Re AC, Horvath AO, Symonds D, Ackert M, Wampold BE. Substance use disorders and racial/ethnic minorities matter: a meta-analytic examination of the relation between alliance and outcome. Journal of counseling psychology. 2013 Oct 1; 60(4):610-6.
  135. Finney JW, Moos RH, Timko C. The course of treated and untreated substance use disorders: Remission and resolution, relapse and mortality. In: Addictions: A Comprehensive Guidebook. 2nd ed. New York, NY: Oxford University Press; 2013. 108-131 p.
  136. Oliva EM, Bowe T, Harris AH, Trafton JA. Datapoints: false starts in psychotherapy for substance use disorders and PTSD in the VHA. Psychiatric services (Washington, D.C.). 2013 Aug 1; 64(8):722.
  137. Frakt AB, Trafton J, Wallace A, Neuman M, Pizer S. Directed funding to address under-provision of treatment for substance use disorders: a quantitative study. Implementation science : IS. 2013 Jul 18; 8:79.
  138. Rosen AK, Chen Qi, O'Brien W, Borzecki AM, Frakt AB, Shwartz M, Bauer MS. Assessing the Impact of Serious Mental Illness (SMI) and Substance Use Disorders (SUD) on Risk of Readmission for Patients with Acute Myocardial Infarction, Heart Failure, and Pneumonia in the Veterans Health Administration (VA). Presented at: AcademyHealth Annual Research Meeting; 2013 Jun 25; Baltimore, MD.
  139. Gallagher RM. Co-occurring chronic pain and substance use disorders: clinical challenges and promising treatment approaches. Paper presented at: American Pain Society Annual Meeting; 2013 May 9; New Orleans, LA.
  140. Mittal D. Maintenance of Certification Symposium: The feedback modules of the performance in practice component of the ABPN MOC program substance use disorders. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2013 Mar 14; Los Angeles, CA.
  141. Hanks D. Emerging Evidence-1: Feb '13-Substance Use Disorders and Mental Health. 2013 Feb 28; 4(1).
  142. Bohnert KM, Ilgen MA, Rosen CS, Desai RA, Austin K, Blow FC. The association between substance use disorders and mortality among a cohort of Veterans with posttraumatic stress disorder: variation by age cohort and mortality type. Drug and Alcohol Dependence. 2013 Feb 1; 128(1-2):98-103.
  143. Gordon AJ. Substance use disorders among homeless in HPACTS: challenges and opportunities. [Cyberseminar]. 2012 Nov 5.
  144. Adams CE, Gabriele JM, Baillie LE, Dubbert PM. Tobacco use and substance use disorders as predictors of postoperative weight loss 2 years after bariatric surgery. The journal of behavioral health services & research. 2012 Oct 1; 39(4):462-71.
  145. Tracy S, Tavakoli S, Stolpner S, Trafton JA. Treating Substance Use Disorders within the Veterans Affairs Health Care System. In: Miller TW, editor. The Praeger Handbook of Veterans' Health [4 volumes]: History, Challenges, Issues, and Developments. 3rd ed. New York, NY: Praeger; 2012. Chapter 6. 169-198 p.
  146. Cucciare MA, Weingardt KR, Greene CJ, Hoffman J. Current trends in using Internet and mobile technology to support the treatment of substance use disorders. Current drug abuse reviews. 2012 Sep 1; 5(3):172-7.
  147. Hawkins EJ, Grossbard J, Benbow J, Nacev V, Kivlahan DR. Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel. Military medicine. 2012 Aug 1; 177(8 Suppl):29-38.
  148. Grossbard JR, Hawkins EJ, Williams EC, Rubinsky AF, Lapham GT, Johnson-Chavez M, Bradley KA. Rates of Alcohol Misuse and Follow-Up Care among OEF/OIF Veterans in VA: Associations with Substance Use Disorders and PTSD. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 19; National Harbor, MD.
  149. Kulkarni M, Oliva EM, Timko C, Trafton JA, Kimerling R. Patterns of Specialty Care Utilization by Veterans with PTSD and Substance Use Disorders. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 16; National Harbor, MD.
  150. Wagner TH, Harris AH, Moos RH, McKellar JD. Assessing the Efficacy of Telephone Monitoring among Veterans with Substance Use Disorders. Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 16; National Harbor, MD.
  151. Cucciare MA, Ghaus S, Weingardt KR. Symposia: Randomized Controlled Trials of Web-based interventions for alcohol and substance use disorders: Results and Future Directions. Presented at: Research Society on Alcoholism Annual Scientific Meeting; 2012 Jun 26; San Francisco, CA.
  152. Kulkarni M, Oliva EM, Timko C, Trafton JA, Kimerling R. Examining Patterns of Special Care Utilization by Veterans with PTSD and Substance Use Disorders. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2012 Jun 24; San Francisco, CA.
  153. Humphreys K. Federal policy on criminal offenders who have substance use disorders: how can we maximize public health and public safety? Substance Abuse. 2012 May 17; 33(1):5-8.
  154. Adams C, Gabriele J, Dubbert PM. Tobacco Use and Substance Use Disorders as Predictors of Postoperative Weight Loss Two Years After Bariatric Surgery. Paper presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2012 Apr 11; New Orleans, LA.
  155. Harpaz-Rotem I, Rosenheck RA, Desai R. Residential treatment for homeless female veterans with psychiatric and substance use disorders: effect on 1-year clinical outcomes. Journal of rehabilitation research and development. 2012 Apr 5; 48(8):891-9.
  156. Nazarian D, Kimerling R, Frayne SM. Posttraumatic stress disorder, substance use disorders, and medical comorbidity among returning U.S. veterans. Journal of traumatic stress. 2012 Apr 1; 25(2):220-5.
  157. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community mental health journal. 2012 Apr 1; 48(2):127-32.
  158. Frayne SM, Carney DV. VA Women’s Health Practice-Based Research Network (Teleconference). To the National VA Substance Use Disorders QUERI Specialty Care Workgroup. 2012 Mar 8.
  159. Rodrigues S, Kline A, Sawh L, Smelson DA, O'Connor K, Kane V, Kuhn J, Serper M, Ziedonis D. Childhood experiences and demographic characteristics of homeless veterans with co-occurring mental health and substance use disorders in MISSION. Poster session presented at: American Psychopathological Association Annual Meeting; 2012 Mar 6; New York, NY.
  160. Ilgen MA, Conner KR, Roeder KM, Blow FC, Austin K, Valenstein M. Patterns of treatment utilization before suicide among male veterans with substance use disorders. American journal of public health. 2012 Mar 1; 102 Suppl 1:S88-92.
  161. Lemke S, Schaefer JA. Addressing substance use disorders in VA nursing homes. Journal of social work practice in the addictions. 2012 Feb 22; 12(1):89-106.
  162. Bohnert AS, Ilgen MA, Ignacio RV, McCarthy JF, Valenstein M, Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. The American journal of psychiatry. 2012 Jan 1; 169(1):64-70.
  163. Chermack ST, Bohnert AS, Price AM, Austin K, Ilgen MA. Substance use disorders and homicide death in veterans. Journal of studies on alcohol and drugs. 2012 Jan 1; 73(1):10-4.
  164. Santa Ana EJ, Stallings DL, Rounsaville BJ, Martino S. Development of an in-home telehealth program for outpatient veterans with substance use disorders. Psychological Services. 2013 Aug 1; 10(3):304-314.
  165. Austin J, McKellar JD, Moos R. The influence of co-occurring axis I disorders on treatment utilization and outcome in homeless patients with substance use disorders. Addictive Behaviors. 2011 Sep 1; 36(9):941-4.
  166. Harris AH. Developing and Validating Metrics of Uniform Handbook Elements Related to Substance Use Disorders (SUD). Presented at: VA Mental Health Annual Conference; 2011 Aug 24; Baltimore, MD.
  167. Seal KH, Cohen G, Waldrop A, Cohen BE, Maguen S, Ren L. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: Implications for screening, diagnosis and treatment. Drug and Alcohol Dependence. 2011 Jul 1; 116(1-3):93-101.
  168. Hagedorn HJ. Rewarding Early Abstinence and Treatment Participation: the effect of motivational incentives on substance use disorders treatment outcomes. Paper presented at: AcademyHealth Annual Research Meeting; 2011 Jun 14; Seattle, WA.
  169. Damschroder LJ, Hagedorn HJ. A guiding framework and approach for implementation research in substance use disorders treatment. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2011 Jun 1; 25(2):194-205.
  170. Finney JW, Hagedorn HJ. Introduction to a special section on implementing evidence-based interventions for substance use disorders. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2011 Jun 1; 25(2):191-3.
  171. Smith MW, Lemke S, Schaefer J. Substance use disorders and health care costs among veterans affairs nursing home residents. Medical care. 2011 Jun 1; 49(6):538-44.
  172. Hagedorn HJ. Implementing motivational incentive in VA substance use disorders treatment. Paper presented at: VA VISN 23 Mental Health Research Conference; 2011 May 5; Sioux Falls, SD.
  173. Ilgen MA, Roeder KM, Webster L, Mowbray OP, Perron BE, Chermack ST, Bohnert AS. Measuring pain medication expectancies in adults treated for substance use disorders. Drug and Alcohol Dependence. 2011 May 1; 115(1-2):51-6.
  174. Bohnert AS, Zivin K, Welsh DE, Kilbourne AM. Ratings of patient-provider communication among veterans: serious mental illnesses, substance use disorders, and the moderating role of trust. Health communication. 2011 Apr 1; 26(3):267-74.
  175. Humphreys KN. Responding to Substance Use Disorders in Military Personnel and their Dependents. Paper presented at: Institute of Medicine: Prevention, Diagnosis, Treatment and Management of Substance Use Disorders in the U.S. Armed Forces Conference; 2011 Mar 30; Washington, DC.
  176. Nazarian D, Kimerling R, Frayne SM. Association between PTSD, substance use disorders, and medical conditions among returning Veterans. Paper presented at: American Psychosomatic Society Annual Scientific Meeting; 2011 Mar 10; San Antonio, TX.
  177. Hagedorn HJ, Noorbaloochi S, Rimmele CT, Kivlahan DR. Rewarding Early Abstinence and Treatment Participation (REAP): The Effect of Motivational Incentives on Substance Use Disorders Treatment Outcomes. Paper presented at: VA HSR&D National Meeting; 2011 Feb 17; Baltimore, MD.
  178. McGlynn G, Hecht MI, Hagedorn H. Short Video-10: Mental Health and Substance Use Disorders, by Hildi Hagedorn. 2010 Dec 2; 1(10).
  179. Frueh BC, Paul LA, Yeager D, Grubaugh AL, Magruder KM. Substance use disorders in Veterans Affairs primary care clinics and relations to mental health outcomes. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2010 Nov 18; San Francisco, CA.
  180. Humphreys KN, McLellan AT. Brief intervention, treatment, and recovery support services for Americans who have substance use disorders: An overview of policy in the Obama administration. Psychological Services. 2010 Nov 1; 7(4):275-284.
  181. Humphreys KN. Managing Substance Use Disorders in Primary Care: Lessons from Developed and Developing Countries. Presented at: World Congress of Social Psychiatry; 2010 Oct 26; Marrakech, Morocco.
  182. Rubinsky AF, Lapham GT, Kivlahan DR, Williams EC, Hawkins EJ, Bradley KA. Prevalence of Previously Recognized Alcohol and Other Substance Use Disorders among VA Patients who Screen Positive for Alcohol Misuse. Presented at: AcademyHealth Annual Fall Seminar; 2010 Sep 27; Boston, MA.
  183. Ilgen MA, Perron B, Czyz EK, McCammon RJ, Trafton J. The timing of onset of pain and substance use disorders. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2010 Sep 1; 19(5):409-15.
  184. Tiet QQ, Schutte KK. Detection rates of substance use disorders. Paper presented at: American Psychological Association Annual Convention; 2010 Aug 12; San Diego, CA.
  185. Edlund MJ, Harris KM, Koenig HG, Han X, Sullivan G, Mattox R, Tang L. Religiosity and decreased risk of substance use disorders: is the effect mediated by social support or mental health status? Social psychiatry and psychiatric epidemiology. 2010 Aug 1; 45(8):827-36.
  186. Tsai J, Bond GR, Salyers MP, Godfrey JL, Davis KE. Housing preferences and choices among adults with mental illness and substance use disorders: a qualitative study. Community mental health journal. 2010 Aug 1; 46(4):381-8.
  187. Weitlauf JC, Waldrop A, Manning E, Jones S, Finney JW. Impact of substance use disorders and PTSD on receipt of cervical cancer screening. Presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 14; Arlington, VA.
  188. Baldwin ML, Marcus SC, De Simone J. Job loss discrimination and former substance use disorders. Drug and Alcohol Dependence. 2010 Jul 1; 110(1-2):1-7.
  189. Lemke S, Schaefer JA. VA nursing home residents with substance use disorders: Mental health comorbidities, functioning, and problem behaviors. Aging & mental health. 2010 Jul 1; 14(5):593-602.
  190. Nazarian D, Kimerling R, Frayne SM. PTSD, substance use disorders, and medical comorbidity among women and men returning Veterans in primary care: A key role for behavioral medicine. Presented at: VA HSR&D Field-Based Women's Health Meeting; 2010 Jul 1; Arlington, VA.
  191. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivlahan D. Rewarding Early Abstinence and Treatment Participation in Substance Use Disorders Treatment. Poster session presented at: AcademyHealth Annual Research Meeting; 2010 Jun 28; Boston, MA.
  192. Bohnert AS. The impact of psychiatric and substance use disorders on the risk of fatal accidental overdose among Veterans. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2010 Jun 14; Scottsdale, AZ.
  193. Hagedorn HJ, Heideman PW. The relationship between baseline Organizational Readiness to Change Assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study. Implementation science : IS. 2010 Jun 14; 5:46.
  194. Weingardt KR. Using technology to support screening, identification and early intervention for psychiatric and substance use disorders. Paper presented at: VA Psychology Leadership Conference; 2010 May 14; San Antonio, TX.
  195. Nazarian D, Kimerling R, Frayne SM. PTSD, Substance Use Disorders, and Medical Comorbidity among OEF/OIF Veterans in Primary Care: Prevalence and Implications for Behavioral Medicine Interventions. Paper presented at: VA HSR&D Field-Based Mental Health and Substance Use Disorders Meeting; 2010 Apr 28; Little Rock, AR.
  196. Harris AH. Can We Strengthen the Links Between Process Quality Measures and Outcomes? Performance Measurement for Substance Use Disorders: A Research Agenda. Paper presented at: Substance Abuse and Mental Health Services Administration / National Institute on Drug Abuse Meeting; 2010 Mar 24; Washington, DC.
  197. Humphreys KN. Policies for improving systems of care for substance use disorders. Presented at: International Society for the Study of Drug Policy Annual Conference; 2010 Mar 23; Santa Monica, CA.
  198. Timko C, Sutkowi A, Moos R. Patients with dual diagnoses or substance use disorders only: 12-step group participation and 1-year outcomes. Substance use & misuse. 2010 Mar 1; 45(4):613-27.
  199. Ilgen MA, Burnette ML, Conner KR, Czyz E, Murray R, Chermack S. The association between violence and lifetime suicidal thoughts and behaviors in individuals treated for substance use disorders. Addictive Behaviors. 2010 Feb 1; 35(2):111-5.
  200. Hagedorn H, Leighton T, Heim L. Assessment of a hepatitis educational group for veterans with substance use disorders. The American journal of drug and alcohol abuse. 2010 Jan 1; 36(1):57-60.
  201. Henry SR, Hagedorn HJ, Feld JE, Golden JF, Horns HL, Knapp HE, Anaya HD. A formative evaluation of organizational readiness to implement nurse-initiated HIV rapid testing in two veterans health administration substance use disorders clinics. Journal of HIV/AIDS and Social Services. 2010 Jan 1; 9(1):7-26.
  202. Brady KT, Tuerk PW, Back SE, Saladin ME, Waldrop AE, Myrick H. Combat PTSD and Substance Use Disorders. Journal of Addictive Medicine. 2009 Dec 15; 3(4):179-188.
  203. Tuerk P, Brady KT, Grubaugh AL. Clinical Case Discussion: Combat PTSD and Substance Use Disorders. Journal of addiction medicine. 2009 Dec 1; 3(4):189-93.
  204. Humphreys KN. Lessons from the VA experience about how the federal Government can improve the treatment of substance use disorders. Presented at: Tory Shadow Cabinet and Backbench Members of Parliament Briefing; Washington, DC. 2009 Nov 22.
  205. Banerjea R, Pogach LM, Smelson DA, Sambamoorthi U. Multi-morbidity in Physical Illness and Co-occurring Mental Illness and Substance Use Disorders: Who are at Risk? Poster session presented at: American Public Health Association Annual Meeting and Exposition; 2009 Nov 7; Philadelphia, PA.
  206. Banerjea R, Findley PA, Smith B, Findley T, Sambamoorthi U. Co-occurring medical and mental illness and substance use disorders among veteran clinic users with spinal cord injury patients with complexities. Spinal Cord. 2009 Nov 1; 47(11):789-95.
  207. Banerjea R, Pogach LM, Smelson D, Sambamoorthi U. Mental illness and substance use disorders among women veterans with diabetes. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2009 Nov 1; 19(6):446-56.
  208. Banerjea R, Findley P, Findley TW, Sambamoorthi U. Prevalence of Mental Illness and Substance Use Disorders and their Impact on Mortality among Veteran Clinic Users with Spinal Cord Injury. Paper presented at: Spinal Cord Medicine and Rehabilitation Annual Congress; 2009 Sep 24; Dallas, TX.
  209. Cucciare MA, Weingardt KR, Humphreys K. How Internet technology can improve the quality of care for substance use disorders. Current drug abuse reviews. 2009 Sep 1; 2(3):256-62.
  210. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivalan D. Effectiveness of a Contingency Management Intervention for Veterans with Substance Use Disorders. Presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2009 Jul 1; Baltimore, MD.
  211. Hagedorn HJ, Noorbaloochi S, Rimmele C, Kivlahan D. Effectiveness of a Contingency Management Intervention for Veterans with Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL.
  212. Leighton TR, Heim LA, Hagedorn HJ. Assessment of a Hepatitis Education Group Serving Veterans in a Substance Use Disorders Clinic. Poster session presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Chicago, IL.
  213. Thomas CP, Seidmann MR, Horgan C, Miller K, Harris AH. Measuring Performance in Use of Pharmacotherapy for Substance Use Disorders in Different Health Systems. Paper presented at: AcademyHealth Annual Research Meeting; 2009 Jun 28; Boston, MA.
  214. Murray RL, Chermack ST, Walton MA, Massey LS, Cunningham R, Barry KL, De Chavez P, Booth BM, Blow FC. Treatment Interests Among Individuals With Substance Use Disorders And A Past-Year History of Violence: Findings From An Emergency Department Study. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2009 Jun 25; San Diego, CA.
  215. Al-Hasnawi SM, Aqrawi R, Sadik S, Humphreys K. Datapoints: Iraqi psychiatrists' perceptions of substance use disorders among patients. Psychiatric services (Washington, D.C.). 2009 Jun 1; 60(6):728.
  216. Smith MW, Ananth L, Chow A, Lemke S, Schaefer JA. Costs of care for VA nursing home patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2009 Feb 24; Baltimore, MD.
  217. Bohnert A, Zivin KZ, Welsh D, Kilbourne AM. Patient-Provider communication among Veterans with Serious Mental Illnesses and Substance Use Disorders. Poster session presented at: VA HSR&D National Meeting; 2009 Feb 13; Baltimore, MD.
  218. Findley P, Findley TW, Banerjea R, Sambamoorthi U. Mental Illness, Substance Use Disorders and Mortality among Veteran Clinic Users with Spinal Cord Injury. Paper presented at: VA HSR&D National Meeting; 2009 Feb 11; Baltimore, MD.
  219. Smith MW, Lemke S, Schaefer JA, Chow A, Ananth L. Nursing home patients with substance use disorders: Implications for cost of care. Presented at: VA HSR&D National Meeting; 2009 Feb 11; Baltimore, MD.
  220. Curran GM, Sullivan G, Williams K, Han X, Allee E, Kotrla KJ. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC emergency medicine. 2008 Dec 3; 8:17.
  221. Weingardt KR. Technology-based training in Cognitive Behavioral Therapy for Substance Use Disorders: Does a flexible training model improve learner outcomes? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2008 Nov 15; Orlando, FL.
  222. Humphreys KN. Why cost offset studies do not convince medical centers to expand treatment for substance use disorders. Paper presented at: Society for the Study of Addiction Annual Symposium; 2008 Nov 12; York, United Kingdom.
  223. Ilgen MA, Hu KU, Moos RH, McKellar J. Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders. Psychiatric services (Washington, D.C.). 2008 Sep 1; 59(9):982-8.
  224. Banerjea R, Sambamoorthi U, Smelson D, Pogach LM. Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. The journal of behavioral health services & research. 2008 Jul 1; 35(3):290-303.
  225. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 1; 36(1):39-45.
  226. Murray, Chermack ST, Walton, Winters, Blow, Booth. Psychological aggression, physical aggression and injury in non-partner relationships among men and women in treatment for substance use disorders. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2008 Jun 29; Washington, DC.
  227. Banerjea R, Sambamoorthi U, Pogach LM, Weaver F, Findley TW. Mental Illness and Substance Use Disorders Among Veteran Clinic Users with Spinal Cord Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 15; Washington, DC.
  228. Hagedorn H, Rettmann N, Dieperink E, Durfee J, Aqel B. Seroconversion Rates after Hepatitis B Vaccination in Patients Seeking Treatment for Substance Use Disorders. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
  229. Smith MW, Lemke S, Schaefer J, Chow A, Ananth L. Nursing home patients with substance use disorders: Implications for cost of care. Poster session presented at: AcademyHealth Annual Research Meeting; 2008 Jun 8; Washington, DC.
  230. Laffaye C, McKellar JD, Ilgen MA, Moos RH. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders. Addiction. 2008 Apr 1; 103(4):671-80.
  231. Burnette ML, Lucas E, Ilgen M, Frayne SM, Mayo J, Weitlauf JC. Prevalence and health correlates of prostitution among patients entering treatment for substance use disorders. Archives of general psychiatry. 2008 Mar 1; 65(3):337-44.
  232. Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs. 2008 Jan 1; 22(11):903-16.
  233. Timko C. Substance use disorders and interpersonal violence. AACN clinical issues. 2008 Jan 1; 12(1):43-54.
  234. Finney JW. Treatment processes and mediators of substance use disorders treatment effects: the benefits of side road excursions. Alcoholism, clinical and experimental research. 2007 Oct 1; 31(10 Suppl):80s-83s.
  235. Gardner TJ, Kosten TR. Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. The American journal of drug and alcohol abuse. 2007 Oct 1; 33(6):765-7.
  236. Gardner TJ, Kosten TR. Pharmacotherapeutic environments for substance use disorders. The American journal of drug and alcohol abuse. 2007 Oct 1; 33(5):627-9.
  237. Dowdy R, Deal M, Benbow J, Reoux J, Barns R, Bush K, Kivlahan DR. Care management promotes access, engagement and empowerment for difficult to serve veterans with co-occurring psychiatric and substance use disorders. Presented at: VA Transforming Mental Health Care Conference; 2007 Jul 19; Washington, DC.
  238. Massey LS, Walton MA, Murray RM, Barry KL, Chermack ST, Cunningham RM, Booth BM, Blow FC. Predictors of Substance Use Disorders Among Patients Presenting to an Inner-City ER OACH to Prevention. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2007 Jul 12; Chicago, IL.
  239. Hagedorn H, Dieperink E, Dingmann D, Durfee J, Ho SB, Isenhart C, Rettmann N, Willenbring M. The Liver Health Initiative: Promoting Hepatitis Services in Substance Use Disorders Treatment Clinics. Poster session presented at: AcademyHealth Annual Research Meeting; 2007 Jun 4; Orlando, FL.
  240. Moos RH. Theory-based processes that promote the remission of substance use disorders. Clinical Psychology Review. 2007 Jun 1; 27(5):537-51.
  241. Moos RH. Theory-based active ingredients of effective treatments for substance use disorders. Drug and Alcohol Dependence. 2007 May 11; 88(2-3):109-21.
  242. Dookeran NM, Burgess J, Bowman C, Chen Y, Asch S, Gifford A. HIV testing in adults with alcohol and other substance use disorders. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2007 Apr 26; Toronto, Canada.
  243. Schutte K, Ilgen M, Tiet QQ. Patient and program characteristics predicting improved outcomes among individuals with co-occurring psychiatric and substance use disorders. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 21; Arlington, VA.
  244. Tiet QQ, Schutte K. Substance use disorders interact with depressive symptoms to predict depressive outcomes. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 21; Arlington, VA.
  245. Finney J, Wilbourne P, Moos R. Psychosocial treatments for substance use disorders. In: A guide to treatments that work. New York, NY: Oxford University Press; 2007. 179-202 p.
  246. Tracy SW, Trafton JA, Weingardt KR, Aton EG, Humphreys K. How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. Psychiatric services (Washington, D.C.). 2007 Feb 1; 58(2):266-9.
  247. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006 Nov 1; 101(11):1546-60.
  248. Oslin DW, Llorente MD, Malphurs J. Substance use disorders in the elderly. In: Principles and Practice of Geriatric Psychiatry. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2006.
  249. McKellar J, Kelly J, Harris A, Moos R. Pretreatment and during treatment risk factors for dropout among patients with substance use disorders. Addictive Behaviors. 2006 Mar 1; 31(3):450-60.
  250. Ilgen MA, Tiet Q, McKellar J, Barnett P, Luna Y, Finney JW. Treatment intensity and symptom severity in patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2006 Feb 1; Arlington, VA.
  251. Kilbourne AM, Salloum I, Dausey D, Cornelius JR, Conigliaro J, Xu X, Pincus HA. Quality of care for substance use disorders in patients with serious mental illness. Journal of substance abuse treatment. 2006 Jan 1; 30(1):73-7.
  252. Lebow J, Kelly J, Knobloch-Fedders LM, Moos R. Relationship Factors in Treating Substance Use Disorders. In: Castonguay LG, Beutler LE, editors. Principles of Therapeutic Change That Work. New York, NY: Oxford University Press; 2006. Chapter 15. 293-317 p.
  253. Hagedorn H. The Liver Health Initiative: Integrating Hepatitis Prevention and Referral Services into Substance Use Disorders Treatment. Paper presented at: Agency for Healthcare Research and Quality Translating Research Into Practice and Policy Annual Meeting; 2005 Oct 1; Washington, DC.
  254. Owen RR, Finney JW, Magruder KM. Report of the HSR&D Field Based Science Advisors for Special Populations: An analysis of VA and non-VA health services research portfolios in mental health, substance use disorders, and posttraumatic stress disorder. Little Rock, AR: Center for Mental Healthcare and Outcomes Research; 2005 Sep 1. Report No.: 1.
  255. Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of psychiatric practice. 2005 Sep 1; 11(5):315-39.
  256. Johnson JE, Finney JW, Moos RH. Predictors of 5-year mortality following inpatient/residential group treatment for substance use disorders. Addictive Behaviors. 2005 Aug 1; 30(7):1300-16.
  257. Hagedorn H, Willenbring ML, Dieperink E, Pexa N, Dingmann D, Durfee J, Ho S. The Liver Health Initiative: Coordinating Hepatitis Prevention and Treatment Referral through a Substance Use Disorders Clinic. Poster session presented at: AcademyHealth Annual Research Meeting; 2005 Jun 1; Boston, MA.
  258. Moos RH. Iatrogenic effects of psychosocial interventions for substance use disorders: prevalence, predictors, prevention. Addiction. 2005 May 1; 100(5):595-604.
  259. Moggi F, Giovanoli A, Moos R. Swiss and United States treatment programs for substance use disorders: Program characteristics, psychiatric comorbidity, and one-year outcomes. Paper presented at: European Psychiatric Association Annual Congress; 2005 Apr 1; Munich, Germany.
  260. DeMarce J, Stephens R, Lash S, Grambow SC. Comorbid Psychiatric Disorders with Substance Use Disorders: Does Comorbidity Moderate Rates of Aftercare Attendance and Substance Use Outcomes? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA.
  261. Moos R. How Can Treatment and Clients Inform and Influence Research on Substance Use Disorders. Paper presented at: Choice, Behavioural Economics, and Addiction Annual Conference; 2004 Nov 1; Brisbane, Australia.
  262. Ilgen M, Tiet Q. Treatment setting and suicidality in patients with substance use disorders. Paper presented at: VA HSR&D National Meeting; 2004 Mar 1; Washington, DC.
  263. Tracy S, Trafton J, Humphreys K. VA psychiatry programs underestimate the prevalence of patients' substance use disorders and rarely provide specialized substance use disorder treatment. Veterans Affairs Central Office; 2004 Jan 1.
  264. Curran GM, Kirchner JE, Allee E, Booth BM. Datapoints: detection of substance use disorders in veterans affairs primary care clinics. Psychiatric services (Washington, D.C.). 2003 Oct 1; 54(10):1326.
  265. Humphreys K. Substance use disorders and juvenile justice. Paper presented at: American Academy of Child and Adolescent Psychiatry Annual Meeting; 2003 Oct 1; San Francisco, CA.
  266. Kelly J, Humphreys K. Self-help for substance use disorders: Evidence of effectiveness and strategies to maximize benefits. Paper presented at: Treatment of Addictive Disorders Annual Conference; 2003 Sep 1; Biloxi, MI.
  267. Kelly JF, McKellar JD, Moos R. Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes. Addiction. 2003 Apr 1; 98(4):499-508.
  268. Brennan PL, Nichol AC, Moos RH. Older and younger patients with substance use disorders: outpatient mental health service use and functioning over a 12-month interval. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2003 Mar 1; 17(1):42-8.
  269. Ritsher JB, McKellar JD, Finney JW, Otilingam PG, Moos RH. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. Journal of Studies On Alcohol. 2002 Nov 1; 63(6):709-15.
  270. Brennan PL, Nichols KA, Moos RH. Long-term use of VA mental health services by older patients with substance use disorders. Psychiatric services (Washington, D.C.). 2002 Jul 1; 53(7):836-41.
  271. Curran GM, Kirchner JE, Booth BM. Detection of substance use disorders in VA primary care clinics. Paper presented at: Research Society on Alcoholism Annual Scientific Meeting; 2002 Jun 5; San Francisco, CA.
  272. Otilingam PG, Ritsher JB, Finney JW, Moos RH, Suchinsky RT. Outcomes Monitoring for Patients with Substance Use Disorders: V. Cohort 3 Patients' Treatment and Treatment Outcomes. Department of Veterans Affairs; 2002 Apr 1.
  273. Whitney S, Kelly J, Myers M, Brown S. Parental substance use, family support and outcome following treatment for adolescent psychoactive substance use disorders. Journal of Child & Adolescent Substance Abuse. 2002 Apr 1; 11(4):67-81.
  274. Moos RH, Nichol AC, Moos BS. Risk factors for symptom exacerbation among treated patients with substance use disorders. Addiction. 2002 Jan 1; 97(1):75-85.
  275. Willenbring M, Kivlahan D, Grillo M. Evidence-based clinical practice guidelines in substance use disorders: a survey of VA substance abuse program leaders. Palo Alto, CA: QUERI Substance Abuse Module; 2001 Sep 15.
  276. Kivlahan D, Miller S, Willenbring M, McNicholas L. VHA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders in the Primary Care setting. Washington, DC: Office of Performance and Quality, VHA and Quality Management Directorate, United States Army MEDCOM; 2001 Apr 1. Report No.: Draft Version 1.0.
  277. Booth BM, Blow FC, Loveland Cook CA. Persistence of impaired functioning and psychological distress after medical hospitalization for men with co-occurring psychiatric and substance use disorders. Journal of general internal medicine. 2001 Jan 1; 16(1):57-65.
  278. Brennan PL, Kagay CR, Geppert JJ, Moos RH. Predictors and outcomes of outpatient mental health care: a 4-year prospective study of elderly Medicare patients with substance use disorders. Medical care. 2001 Jan 1; 39(1):39-49.
  279. Brennan PL, Kagay CR, Geppert JJ, Moos RH. Elderly Medicare inpatients with substance use disorders: characteristics and predictors of hospital readmissions over a four-year interval. Journal of Studies On Alcohol. 2000 Nov 1; 61(6):891-5.
  280. Gold PB, Meisler N, DuRoss D, Santos AB. Assertive community treatment for indigent persons with severe substance use disorders. Paper presented at: American Public Health Association Annual Meeting and Exposition; 2000 Nov 1; Boston, MA.
  281. Moos RH, Finney JW, Federman EB, Suchinsky R. Specialty mental health care improves patients' outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. Journal of Studies On Alcohol. 2000 Sep 1; 61(5):704-13.
  282. Moos RH, Finney JW, Suchinsky RT. Outcomes monitoring for patients with substance use disorders: IV. Cohort 2 patients' 6-12 month treatment outcomes. 2000 Apr 1. 1-48 p.
  283. Finney JW, Moos RH, Timko C. The course of treated and untreated substance use disorders: Remission and resolution, relapse and mortality. In: McCrady BS, Epstein EE, editors. Addictions: A comprehensive guidebook. New York, NY: Oxford University Press; 1999.
  284. Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric services (Washington, D.C.). 1999 Dec 1; 50(12):1577-83.
  285. Moos RH, Federman B, Finney J, Suchinsky R. Outcomes monitoring for patients with substance use disorders: II. Cohort 1 patients' 6-12 month treatment outcomes. PERC, HSR&D Center for Health Care Evaluation, MHSHG; 1999 Sep 1. Report No.: 2.
  286. Moos RH, Federman B, Finney J, Suchinsky R. Outcomes monitoring for patients with substance use disorders: III. Cohort 2 patients' characteristics and treatment at baseline. Palo Alto, CA: PERC, HSR&D Center for Health Care Evaluation, MHSHG; 1999 Sep 1. Report No.: 3.
  287. Chun C, Ouimette PC, Kimerling R, Moos R. Gender differences in addiction severity, health status, and psychosocial functioning in veterans with substance use disorders. Paper presented at: VA HSR&D National Meeting; 1999 Feb 1; Washington, DC.
  288. Blow FC, Barry KL, BootsMiller BJ, Copeland LA, McCormick R, Visnic S. Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders. Journal of psychiatric research. 1998 Sep 1; 32(5):311-9.
  289. Kirchner JE, Owen RR, Nordquist C, Fischer EP. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric services (Washington, D.C.). 1998 Jan 1; 49(1):82-5.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.